Related Experiment Video

Updated: Aug 15, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

Diagnostic tools for the study of vascular cognitive dysfunction in hypertension and antihypertensive drug research

Andrea Semplicini1, Piero Amodio, Gastone Leonetti

  • 1Department of Clinical and Experimental Medicine, University of Padova, Padova, Italy. andrea.semplicini@unipd.it

Pharmacology & Therapeutics
|October 6, 2005
PubMed

Insights

Antihypertensive treatments reduce stroke mortality but not morbidity. This report identifies tools to study how these drugs impact cognitive decline and vascular dementia (VD).

Area of Science:

  • Neurology
  • Cardiology
  • Gerontology

Background:

  • Arterial hypertension is a primary risk factor for cerebrovascular diseases, significantly reducing mortality but not morbidity.
  • A growing number of patients experience recurrent strokes, cognitive impairment, and disabling consequences of cerebrovascular diseases.
  • The impact of antihypertensive treatment on preventing cognitive dysfunction, particularly vascular dementia, remains debated due to diagnostic challenges.

Purpose of the Study:

  • To identify sensitive and specific diagnostic tools for mild cognitive impairment (MCI) and early dementia.
  • To facilitate research investigating the effects of antihypertensive drugs on vascular dementia (VD).
  • To support observational, longitudinal, and interventional clinical research in this area.

Main Methods:

  • Expert consensus report.
  • Review of existing diagnostic tools for MCI and early dementia.
  • Focus on tools suitable for clinical research.

Main Results:

  • The report enlists currently available diagnostic tools.
  • These tools are validated for sensitivity and specificity in assessing MCI and early dementia.
  • The selected tools are appropriate for use in clinical research settings.

Conclusions:

  • Accurate diagnostic tools are crucial for advancing research on vascular cognitive impairment.
  • Standardized assessment of MCI and early dementia is needed to evaluate antihypertensive treatments' efficacy.
  • Further research is warranted to understand and prevent cognitive decline associated with hypertension and cerebrovascular disease.

More Related Videos

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis05:12

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

Published on: November 22, 2024

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...